The Department of Health and Human Services has announced 13 programs for inclusion in President Biden’s Justice40 Initiative, which was launched as part of the administration’s commitment to environmental justice. The Justice40
More
Alondra Nelson, deputy director for science and society at the Office of Science and Technology Policy, has been appointed by President Joe Biden to serve as OSTP’s director on an interim basis.
More
The National Institutes of Health (NIH) has awarded 11 grants worth $58 million combined over five years to support research initiatives that seek to advance health equity and address health disparities. NIH
More
National Institutes of Health (NIH) Director Francis Collins will step down from his role by the end of year, concluding a 12-year tenure as the agency's leader. He will continue to lead
More
The Government Accountability Office (GAO) has recommended that federal agencies ensure that their conflicts of interest policies address non-financial COI and come up with written procedures to address cases in which researchers
More
NetImpact Strategies, Inc. has won the Portfolio Management Systems Support Services recompete contract to provide digital transformation services for the National Cancer Institute’s Center for Biomedical Informatics and Information Technology. NetImpact will
More
Medical Science & Computing (MSC), a subsidiary of Dovel Technologies, has won one of five spots on a potential five-year, $3.6 billion Scientific, Operations, and Administrative Resources (SOAR) indefinite-delivery/indefinite-quantity contract from the
More
GRSi has secured a potential five-year, $12 million contract to provide technical support services to a National Institutes of Health organization focused on exploring biomedical technology. The Bethesda, Maryland-based information technology company said
More
Federal science and health officials plan to create a research agency within the National Institutes of Health (NIH) to develop technologies that could help detect, prevent and treat cancer, infectious diseases and
More
The Biden administration plans to spend more than $3 billion on projects to discover, develop and manufacture antiviral drugs for the prevention of illness and death from COVID-19. This investment is for
More